Search results for: Chronic Diseases
Filter search results
Reimagining Prevention for a Healthier, More Prosperous Society: Webinar Insights
7 December 2023
Key insights Chronic underfunding and resource reductions resulting from political volatility hinders and sometimes even dismantles advancements in public health. Existing data needs to be optimised using risk stratification to…
Individual, Health System, and Societal Impacts of Anti-seizure Medicine Use During Pregnancy
23 January 2024
…collection of data on prescribing of ASMs, ASM-specific risks, and incidence of co-morbidities. Share this: Download publication Epilepsy is a chronic, neurological disorder characterised by spontaneous and recurrent seizures, which…
Green Healthcare: Are We Asking the Right Questions?
11 September 2024
…rather a chronic lack of headspace for people to prioritise sustainability. Comprehensive data The panel agreed that comprehensive data needs to explicitly link healthcare interventions with environmental factors as well…
Employer Costs from Respiratory Infections
16 December 2024
…2024b). In contrast to more chronic conditions, the direct impacts of respiratory infections (such as influenza, COVID-19 and RSV) tend to be self-limiting and shorter in nature, and therefore their…
GLP-1 Receptor Agonists: Shifting Obesity Management
12 May 2025
…people with obesity (without diabetes) may differ from those managing T2DM. Because they’re not facing a chronic disease requiring lifelong medication, their risk tolerance for side effects may be lower,…
The broader economic benefits of COVID-19 vaccination
13 October 2025
…This is particularly urgent in the face of global trends like demographic ageing and increasing rates of chronic illness among working-age adults. Without this broader perspective, decision-makers risk overlooking the…
Turning around the NHS: Reflections on the 2025 OHE Annual Lecture
14 October 2025
…climb. The proportion of NHS spending devoted to primary care, crucial for managing the chronic conditions projected to grow most rapidly, has fallen from 22% in 2013 to 18% just before…
Martin L. Lee
17 March 2026
…for the treatment of chronic lymphocytic leukemia, multiple myeloma, SLE, rheumatoid arthritis, Type 1 and 2 diabetes, hemophilia B and other rare bleeding disorders, and Stage 4 melanoma. He is…
Is the revised Congressional Budget Office model of new drug development fit for purpose?
6 May 2026
…more predictable returns. For example, a company facing tighter revenue expectations may choose to prioritise late-stage assets in common chronic conditions, where clinical pathways and reimbursement outcomes are well understood,…